Frekentine is a sympathomimetic stimulant marketed as an appetite suppressant. It is known as Tenuate and Tenuate Dospan, is similar to amphetamine, and is an anorectic or anorexigenic medicament.
Frekentine has been found to be effective as medicament to stop smoking. Frekentine stimulates the central nervous system and may increase the heart rate and blood pressure while decreasing appetite.
Marketed as an appetite suppressant, this controlled substance is used to treat obesity, diet, and to counter unipolar disorder. Frekentine is listed by the Food & Drug Administration in pregnancy category B. This means that it is found to not cause harm to an unborn fetus. Expecting mothers should not take this medicament without consulting their physician first.
Frekentine is a controlled substance Schedule IV and can be obtained only with a prescription. It is uncommitted in 25 mg pills and 75mg control-released pills.
Common side effects include nausea, headaches, bouts of insomnia, psychosis, and more serious side effects include pulmonary high blood pressure, and ultimately a stroke.
Less common side effects include xerostalmia, or a metallic taste in foods, blurred vision or photosensitivity, allergies and rashes. More serious side effects include a decrease in the patient’s libido (sexual activity) and can lead to impotence. Neurological and psychological side effects include unipolar disorder, anxiety, drilling headaches, restlessness, tremors, dizziness and seizures.
Caution is required when taking Frekentine, especially when performing activities that include driving or machine operation. Frekentine is a stimulant medicament, which masks tiredness and causes fatigue leading to problems in vision, speech and motion. Note that this medicament can be habit forming.
Patients with a history of heart diseases or high blood pressure are not to take Frekentine, including patients diagnosed with arteriosclerosis or the stiffening of the arteries. Patients with glaucoma should not take this medicament.
Patients taking monoamine oxidase inhibitor medicaments (Monoamine oxidaseIs) within the last two weeks may not take this medicament. Mixing Monoamine oxidaseIs with Frekentine can have a lethal effect on the patient. Patients with a history of medicament and alcohol abuse are prohibited from taking Frekentine. It is habit forming and these patients may have a hard time stopping the use of the medicament.
Frekentine cannot be taken with other anorectic medicaments. Pregnant women should only use this medicament when necessary. Breastfeeding women need to weigh the benefits of taking the medicament against the risk it may bring to the nursing infant prior to taking the medicament.
Frekentine has the following structural formula:
• Molecular formula of Frekentine is C13H19NO
• Chemical IUPAC Name is 2-diethylamino-1-phenylpropan-1-one
• Molecular weight is 205.2961 g/mol
• Frekentine available : 25mg tablets and 75mg tablets
©2007-2017 Medicalook.com All rights reserved